Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS approval · 2014-01-16Clinical Trial Update: Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
This Clinical Trials Update describes an Expanded Access Program for Sofosbuvir with ribavirin, with or without pegylated interferon, to tre…
-
CLINICAL_TRIALS research · 2014-01-16Clinical Trial Update: Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD) [NA]
Prospective clinical study evaluating the role of the immune response in relation to diet in patients with chronic hepatitis C virus infecti…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus. [Phase 1]
Phase 1 study evaluating antiviral activity of a small-molecule direct-acting antiviral agent across multiple doses in subjects with chronic…
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Oxidative Stress and Fatty Acids in Hepatitis C
A completed clinical trial update examining oxidative stress and fatty acids in people with Hepatitis C and hepatic steatosis.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C [Phase 2]
Phase 2 trial evaluating nitazoxanide in combination with peginterferon alfa-2a and ribavirin for chronic hepatitis C completed; results hav…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients [Phase 2]
A Phase 2 trial assessing nitazoxanide combined with peginterferon alfa-2a and ribavirin in treatment-naive chronic hepatitis C patients, wi…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV [NA]
The clinical trial evaluating Hansenula-derived pegylated interferon alpha-2a in Egyptian children with chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C [Phase 2]
A Phase 2 clinical trial update on Miravirsen in chronic hepatitis C patients who are null responders to pegylated interferon alfa plus riba…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554 [Phase 1]
A Phase 1 study evaluating the impact of hepatic impairment on the safety, tolerability, and pharmacokinetics of a single 200 mg dose of PF-…
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of single doses of VBY-376 in healthy adults, completed to support development for …
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C [Phase 3]
Open-label Phase 3 bridging study evaluating telaprevir in treatment-naïve and treatment-experienced Russian patients with genotype 1 chroni…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation [Phase 2]
A Phase 2 study evaluated whether weaning immunosuppression after liver transplantation reduces hepatitis C–related liver damage; the trial …
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection [Phase 2]
Phase 2 trial evaluating GS-5885 (ledipasvir), GS-9451, tegobuvir, and ribavirin in interferon-ineligible or intolerant subjects with chroni…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection [Phase 2]
This Phase 2 trial from Gilead evaluated a four-drug regimen including GS-5885 (ledipasvir), GS-9451, tegobuvir, and ribavirin in patients w…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection [Phase 2]
A Phase 2 trial in treatment-experienced adults with chronic genotype 1 hepatitis C tested a regimen including GS-5885, GS-9451, Tegobuvir, …
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: 5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I (P02538 Pt 2) [Phase 3]
Five-year long-term follow-up from a Phase 3 pediatric trial of PegIntron plus Rebetol for chronic hepatitis C.
-
CLINICAL_TRIALS research · 2013-12-17Clinical Trial Update: Prospective Observational Study of Disease Progression in Chronic Hepatitis C
This is a prospective observational study investigating disease progression in chronic hepatitis C, currently active but not recruiting. Liv…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C [Phase 4]
Phase 4 clinical trial update evaluating pegylated interferon alfa-2a plus low-dose ribavirin in treatment-naïve hemodialysis patients with …
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients [Phase 4]
Phase 4 clinical trial updating on the efficacy of pentoxifylline, interferon alfa, and ribavirin in hepatitis C patients coinfected with HI…
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients [Phase 3]
This clinical trial update reports results from a Phase III study of TMC435 in treatment-naive patients with chronic Hepatitis C genotype 1;…
-
CLINICAL_TRIALS research · 2013-12-09Clinical Trial Update: WEUSKOP5410: Observational Study in ENABLE Clinical Trials
This is a completed observational study (WEUSKOP5410) within ENABLE Clinical Trials sponsored by GlaxoSmithKline, focusing on Hepatitis C.
-
FDA approval · 2013-12-06FDA Approved: SOVALDI — Original Application (Gilead Sciences, Inc.)
The FDA approved Sovaldi (sofosbuvir) from Gilead as the original application, establishing it as a treatment for hepatitis C infection.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390 [Phase 3]
Phase 3 results were posted for a trial in Hepatitis C patients who were non-responders and had previously participated in eltrombopag studi…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection
This clinical trial update reports on associations, outcomes, and genomics related to Hepatitis C and HIV infections, in the context of GB V…
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Long Term Vitamin D Therapy in HCV Treated Patients [Phase 3]
A Phase 3 clinical trial evaluating long-term vitamin D therapy in patients treated for chronic hepatitis C has been terminated.